Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
5.26M
-
Shares change
-
-736K
-
Total reported value, excl. options
-
$19.8M
-
Value change
-
-$2.82M
-
Number of buys
-
20
-
Number of sells
-
-5
-
Price
-
$3.79
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q2 2020
33 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q2 2020.
Protalix BioTherapeutics, Inc. - COM (PLX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.26M shares
.
Largest 10 shareholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC (2.41M shares), UBS OCONNOR LLC (672K shares), RENAISSANCE TECHNOLOGIES LLC (530K shares), Psagot Investment House Ltd. (470K shares), Phoenix Holdings Ltd. (188K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (174K shares), BANK OF MONTREAL /CAN/ (174K shares), JANE STREET GROUP, LLC (144K shares), KENNEDY CAPITAL MANAGEMENT, INC. (101K shares), and ETF MANAGERS GROUP, LLC (93.9K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.